# Oramed Pharmaceuticals Inc.: Form SCHEDULE 13D, filed May 14, 2026

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: SCHEDULE 13D
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 17:19 ET
- Period: not reported
- Accession: 0001213900-26-056837
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390026056837/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390026056837/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390026056837/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-056837. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.